We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nitric Acid Found to Have Key Role in Respiration

By HospiMedica staff writers
Posted on 25 Jun 2002
Researchers have demonstrated that the chemical nitric oxide is an active regulatory molecule in the respiratory process that causes blood vessels to relax or constrict. More...
They conclude that nitric oxide should be considered as the third major blood gas (along with oxygen and carbon dioxide) to be monitored in patients. Their findings were reported in the advance online issue of Nature Medicine on June 3, 2002.

In their studies, investigators tested the responses of the circulatory systems of human subjects in specialized chambers where the investigators could control atmospheric pressure and gas concentrations. They raised or lowered oxygen levels in the chambers and analyzed the response of the subjects' blood cells. This analysis showed that nitric oxide in the blood cells is an active regulatory molecule that causes the oxygen-carrying hemoglobin molecules in red blood cells to undergo subtle shape changes in response to varying concentrations of oxygen. Nitric oxide works by relaxing or contracting blood vessels. The findings explain why blood transfusions or drugs that boost red blood cell production don't work. They could also explain why there is a direct relationship between high red blood cell counts and stroke, heart attack, and hypertension.

"Instead of the total oxygen saturation of blood in the circulatory system, the key determinant of the efficiency of oxygen delivery is the flow of blood in the microvasculature,” said Jonathan Stamler, M.D., a senior member of the Duke research team. "Our data raise the possibility that the level of nitric oxide in the blood may provide physicians with a keen insight into the state of a patient's microvasculature.”




Related Links:
Duke Univ.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.